Ina much-anticipated decision, the U.S. Food and Drug Administration (FDA) has granted approval to bring to market a digital breast tomosynthesis system. The system, called Selenia Dimensions (Dimensions 3-D), is offered by Hologic, Inc, of Bedford, Mass.